23andMe bought by Regeneron in court auction

It has been nearly two months since 23andMe declared bankruptcy and the company has officially been sold. The US biotech company Regeneron has agreed to buy 23andMe and all of its assets for $256 million (even though it was valued at $50 million in March). This purchase marks the end of former 23andMe CEO Anne Wojcicki's bid to buy the company, which included resigning in order to make an independent offer. According to Mark Jensen, Chair and member of the Special Committee of the Board of Directors of 23andMe, Regeneron is offering to keep all of the former company's employees. This decision, "will allow us to continue our mission of helping people access, understand and gain health benefits through greater understanding of the human genome," he said in a release. The announcement also tries to emphasize data protection following 23andMe users' concerns about where their information might end up and, in some cases, deleting their data from the site. “We are pleased to have reached a ... Read full article.